Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: July 2012
-
July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July 12, 2012 – Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Bayer Schering v. Lupin and AstraZeneca v. Apotex for Pharma Patents (Strafford) – 1:00 – 2:30 pm (EDT)…
-
D Young & Co. will be offering its next EPO biotechnology case law webinar on July 18, 2012. The 45-minute webinar will be offered at three times: 4:00 am, 7:00 am, 12:00 pm (all times EDT). Simon O'Brien and Robert Dempster will provide an essential update and live Q&A on EPO biotechnology case law. While…
-
C5 will be holding its 3rd Forum on EU Pharma Regulatory Law on September 25-26, 2012 in Brussels, Belgium. The conference will provide presentations on the following topics: • Unraveling the Complexity to Ensure Effective Implementation of Pharamacovigilance (PV) Legislation• Adopting Effective Risk Management Strategies to Avoid Product Liability Claims• Safeguarding the Integrity of your…
-
The SMi will be holding its 4th annual conference on Biosimilars and Biobetters on September 24-25, 2012 in London, UK. The conference will offer presentations on the following topics: • Clinical approach to biosimilar development;• Development of biosimilar monoclonal antibodies: opportunities and challenges;• Safety in biosimilar development;• Panel discussion: Biosimilars vs. biobetters, so which is…
-
By Donald Zuhn — On Tuesday, the U.S. Patent and Trademark Office issued a memorandum providing guidance for determining subject matter eligibility of process claims involving laws of nature in view of the Supreme Court's decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. The memo, entitled "2012 Interim Procedure for Subject Matter Eligibility Analysis…
-
By Donald Zuhn — A study commissioned by the Partnership for a New American Economy, a bipartisan group of mayors from across the country and business leaders from all sectors of the economy seeking to raise awareness of the economic benefits of sensible immigration reform, shows that 76% of patents issued in 2011 to the…
-
By Andrew Williams — On Monday, in Sciele Pharma Inc. v. Lupin Ltd., the Federal Circuit vacated a preliminary injunction against ANDA-filer Lupin that blocked its sale of generic Fortamet, and remanded the case to the District Court for the District of Delaware for further processing. In so doing, the Federal Circuit reiterated the holding…
-
By Donald Zuhn — The U.S. Patent and Trademark Office announced today that it plans to open three more satellite offices in addition to the satellite office to be opened later this month in Detroit, MI. The additional offices will be located in Dallas, TX; Denver, CO; and in California's Silicon Valley. The announcement ends…
-
By Devanand Crease — After a gestation period of nearly 40 years, and amid the Eurozone crisis, the final form of the unitary European Union (EU) patent and unified patent litigation system was brought in existence on 29 June 2012. It was a troubled labour with much wrangling between the parent member states with some…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cumberland Pharmaceuticals Inc. v. Sagent Agila LLC et al.1:12-cv-00825; filed June 26, 2012 in the District Court of Delaware • Plaintiff: Cumberland Pharmaceuticals Inc.• Defendants: Sagent Agila LLC; Sagent Pharmaceuticals Inc. Infringement of U.S. Patent…
Patent Docs 